Cargando…
A new door opens, but it is essential to accumulate further clinical evidence to control heart failure in diabetes with preserved ejection fraction
TBA.[Image: see text]
Autor principal: | Kashiwagi, Atsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717812/ https://www.ncbi.nlm.nih.gov/pubmed/31228312 http://dx.doi.org/10.1111/jdi.13107 |
Ejemplares similares
-
Modelling the complexity of heart failure with preserved ejection fraction
por: O’Gallagher, Kevin, et al.
Publicado: (2018) -
Heart Failure With Preserved Ejection Fraction: An Opportunity for Reflection
por: Gupta, Deepak K.
Publicado: (2017) -
Strategies for management of heart failure with preserved ejection fraction
por: Winchester, David E.
Publicado: (2019) -
Growing Evidence Linking Microvascular Dysfunction With Heart Failure With Preserved Ejection Fraction
por: Giamouzis, Gregory, et al.
Publicado: (2016) -
Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)